Adolescents' dietary polyphenol intake in relation to serum total antioxidant capacity: the HELENA study.


Journal

International journal of food sciences and nutrition
ISSN: 1465-3478
Titre abrégé: Int J Food Sci Nutr
Pays: England
ID NLM: 9432922

Informations de publication

Date de publication:
Feb 2022
Historique:
pubmed: 17 4 2021
medline: 19 1 2022
entrez: 16 4 2021
Statut: ppublish

Résumé

We evaluated the association between intake of total polyphenols, polyphenol classes and the 10 most consumed individual polyphenols with serum total antioxidant capacity (TAC) in 749 European adolescents (53% girls; 15% overweight; 12.5-17.5 years-old) from the cross-sectional HELENA study of 2006-2007. Dietary polyphenol intake was calculated from two non-consecutive 24-h recalls matched with the Phenol-Explorer database. Multilevel linear models examined the associations between dietary polyphenols and TAC. Polyphenol intake was rather low (median = 321mg/day; p25 = 158; p75 = 536) and TAC was comparable to other literature findings (median = 1.57 mmol/L; p25 = 1.45; p75 = 1.74). Total polyphenol intake, polyphenol classes and the top 10 compounds were not associated with TAC in a linear, quadratic or cubic way in partially or fully confounder-adjusted models. A direct anti-oxidative effect of dietary polyphenol intake was not observed in European adolescents. Polyphenol biomarkers and additional antioxidant measures are needed in future prospective studies to confirm these results.

Identifiants

pubmed: 33858286
doi: 10.1080/09637486.2021.1910631
doi:

Substances chimiques

Antioxidants 0
Polyphenols 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

71-81

Auteurs

Ratih W Wisnuwardani (RW)

Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
Faculty of Public Health, Mulawarman University, Samarinda, East Kalimantan, Indonesia.

Stefaan De Henauw (S)

Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.

Maria Forsner (M)

Department of Nursing, Umeå University, Umeå, Sweden.
School of Education, Health and Social Sciences, Dalarna University, Falun, Sweden.

Frédéric Gottrand (F)

CHU Lille, Inserm U995, Univ. Lille, Lille, France.
International Agency for Research on Cancer, Lyon Cedex 08, France.

Inge Huybrechts (I)

Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
International Agency for Research on Cancer, Lyon Cedex 08, France.

Antonios G Kafatos (AG)

Clinic of Nutrition and Disease Prevention, School of Medicine, University of Crete, Crete, Greece.

Mathilde Kersting (M)

Research Department of Child Nutrition, Pediatric University Clinic, Ruhr-University Bochum, Bochum, Germany.

Viktoria Knaze (V)

International Agency for Research on Cancer, Lyon Cedex 08, France.

Yannis Manios (Y)

Department of Nutrition and Dietetics, Harokopio University, Athens, Greece.

Esther Nova (E)

Department of Metabolism & Nutrition, Immunonutrition Research Group, Institute of Food Science, Technology and Nutrition, Madrid, Spain.

Dénes Molnár (D)

Departments of Pediatrics, Medical School, University of Pécs, Pécs, Hungary.

Joseph A Rothwell (JA)

International Agency for Research on Cancer, Lyon Cedex 08, France.

Augustin Scalbert (A)

International Agency for Research on Cancer, Lyon Cedex 08, France.

Stefania Sette (S)

CREA Research Centre for Food and Nutrition, Rome, Italy.

Kurt Widhalm (K)

Department of Pediatric, Division of Clinical Nutrition, Medical University of Vienna, Vienna, Austria.

Luis A Moreno (LA)

Faculty of Health Science, GENUD (Growth, Exercise, Nutrition and Development) Research Group, University of Zaragoza, Zaragoza, Spain.

Nathalie Michels (N)

Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH